Prevention of febrile neutropenia in chemotherapy-treated cancer patients: Pegylated versus standard myeloid colony stimulating factors. Do we have a choice?

Jean Klastersky; Ahmad Awada

doi:10.1016/j.critrevonc.2010.02.005

Prevention of febrile neutropenia in chemotherapy-treated cancer patients: Pegylated versus standard myeloid colony stimulating factors. Do we have a choice?

Critical Reviews in Oncology/Hematology ◽

10.1016/j.critrevonc.2010.02.005 ◽

2011 ◽

Vol 78 (1) ◽

pp. 17-23 ◽

Cited By ~ 16

Author(s):

Jean Klastersky ◽

Ahmad Awada

Keyword(s):

Febrile Neutropenia ◽

Cancer Patients ◽

Colony Stimulating Factors

Download Full-text

PCN99 Cost-Utility of Granulocyte-Colony Stimulating Factors for Primary Prophylaxis of Chemotherapy Induced Febrile Neutropenia in Breast Cancer Patients in Belgium

Value in Health ◽

10.1016/j.jval.2012.08.2139 ◽

2012 ◽

Vol 15 (7) ◽

pp. A427 ◽

Cited By ~ 1

Author(s):

L. Somers ◽

M. Malfait ◽

A. Danel

Keyword(s):

Breast Cancer ◽

Febrile Neutropenia ◽

Cancer Patients ◽

Primary Prophylaxis ◽

Cost Utility ◽

Breast Cancer Patients ◽

Colony Stimulating Factors

Download Full-text

Faculty of 1000 evaluation for Primary prophylactic colony-stimulating factors for the prevention of chemotherapy-induced febrile neutropenia in breast cancer patients.

F1000 - Post-publication peer review of the biomedical literature ◽

10.3410/f.717962225.793474494 ◽

2013 ◽

Author(s):

Nancy Lin ◽

Ines Vaz-Luis

Keyword(s):

Breast Cancer ◽

Febrile Neutropenia ◽

Cancer Patients ◽

Breast Cancer Patients ◽

Colony Stimulating Factors

Download Full-text

Comparative effectiveness of granulocyte colony-stimulating factors to prevent febrile neutropenia and related complications in cancer patients in clinical practice: A systematic review

Journal of Oncology Pharmacy Practice ◽

10.1177/1078155215625459 ◽

2016 ◽

Vol 22 (5) ◽

pp. 702-716 ◽

Cited By ~ 28

Author(s):

Sarah Mitchell ◽

Xiaoyan Li ◽

Matthew Woods ◽

Jacob Garcia ◽

Kerri Hebard-Massey ◽

...

Keyword(s):

Systematic Review ◽

Clinical Practice ◽

Febrile Neutropenia ◽

Cancer Patients ◽

Comparative Effectiveness ◽

Colony Stimulating Factors

Download Full-text

Use of antimicrobial agents and granulocyte colony stimulating factors for febrile neutropenia in cancer patients in a tertiary care hospital in India

Indian Journal of Cancer ◽

10.4103/0019-509x.73568 ◽

2010 ◽

Vol 47 (4) ◽

pp. 430

Author(s):

V Roy ◽

D Saxena ◽

M Agarwal ◽

AK Bahadur ◽

B Mishra

Keyword(s):

Febrile Neutropenia ◽

Cancer Patients ◽

Antimicrobial Agents ◽

Tertiary Care Hospital ◽

Tertiary Care ◽

Care Hospital ◽

Colony Stimulating Factors

Download Full-text

Cost-Utility of Granulocyte-Colony Stimulating Factors (G-CSFs) for Primary Prophylaxis (PP) of Chemotherapy Induced Febrile Neutropenia (FN) in Breast Cancer Patients in the Netherlands

Value in Health ◽

10.1016/j.jval.2013.08.531 ◽

2013 ◽

Vol 16 (7) ◽

pp. A415

Author(s):

L. Somers ◽

J.N.H. Timmer-Bonte ◽

H. Gelderblom

Keyword(s):

Breast Cancer ◽

The Netherlands ◽

Febrile Neutropenia ◽

Cancer Patients ◽

Primary Prophylaxis ◽

Cost Utility ◽

Breast Cancer Patients ◽

Colony Stimulating Factors

Download Full-text

Colony-stimulating factors for the prevention of chemotherapy induced febrile neutropenia in breast cancer patients

10.1002/14651858.cd007913 ◽

2009 ◽

Cited By ~ 1

Author(s):

Markus Horneber ◽

Stefania Milazzo ◽

Jian Ping Liu ◽

Marcel Zwahlen ◽

Josef Birkmann

Keyword(s):

Breast Cancer ◽

Febrile Neutropenia ◽

Cancer Patients ◽

Breast Cancer Patients ◽

Colony Stimulating Factors

Download Full-text

Primary prophylactic colony-stimulating factors for the prevention of chemotherapy-induced febrile neutropenia in breast cancer patients

Cochrane Database of Systematic Reviews ◽

10.1002/14651858.cd007913.pub2 ◽

2012 ◽

Cited By ~ 13

Author(s):

Peter Renner ◽

Stefania Milazzo ◽

Jian Ping Liu ◽

Marcel Zwahlen ◽

Josef Birkmann ◽

...

Keyword(s):

Breast Cancer ◽

Febrile Neutropenia ◽

Cancer Patients ◽

Breast Cancer Patients ◽

Colony Stimulating Factors

Download Full-text

Cost-Effectiveness and Cost-Utility of Granulocyte Colony-Stimulating Factors in the Primary Prophylaxis of Chemotherapy Induced Febrile Neutropenia (FN) in Breast Cancer Patients in Greece: A Comparative Analysis

Value in Health ◽

10.1016/j.jval.2014.08.2269 ◽

2014 ◽

Vol 17 (7) ◽

pp. A633

Author(s):

G. Kourlaba ◽

E. Palaka ◽

V. Papagiannopoulou ◽

N. Maniadakis

Keyword(s):

Breast Cancer ◽

Comparative Analysis ◽

Cost Effectiveness ◽

Febrile Neutropenia ◽

Cancer Patients ◽

Primary Prophylaxis ◽

Cost Utility ◽

Breast Cancer Patients ◽

Colony Stimulating Factors

Download Full-text

Effectiveness of biosimilar filgrastim vs. original granulocyte colony-stimulating factors in febrile neutropenia prevention in breast cancer patients

European Journal of Clinical Pharmacology ◽

10.1007/s00228-017-2365-5 ◽

2017 ◽

Vol 74 (3) ◽

pp. 315-321 ◽

Cited By ~ 4

Author(s):

Isabel Puértolas ◽

Alberto Frutos Pérez-Surio ◽

María Aránzazu Alcácera ◽

Raquel Andrés ◽

María del Tránsito Salvador

Keyword(s):

Breast Cancer ◽

Febrile Neutropenia ◽

Cancer Patients ◽

Breast Cancer Patients ◽

Colony Stimulating Factors ◽

Biosimilar Filgrastim

Download Full-text

Side effects of using granulocyte-colony stimulating factors as prophylaxis of febrile neutropenia in cancer patients: A systematic review

Critical Reviews in Oncology/Hematology ◽

10.1016/j.critrevonc.2020.103193 ◽

2021 ◽

Vol 157 ◽

pp. 103193

Author(s):

Pietro Lapidari ◽

Ines Vaz-Luis ◽

Antonio Di Meglio

Keyword(s):

Systematic Review ◽

Side Effects ◽

Febrile Neutropenia ◽

Cancer Patients ◽

Colony Stimulating Factors

Download Full-text